1. Home
  2. GCTK vs BREA Comparison

GCTK vs BREA Comparison

Compare GCTK & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • BREA
  • Stock Information
  • Founded
  • GCTK 2001
  • BREA 2022
  • Country
  • GCTK United States
  • BREA Ireland
  • Employees
  • GCTK N/A
  • BREA N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • GCTK Health Care
  • BREA Consumer Discretionary
  • Exchange
  • GCTK Nasdaq
  • BREA Nasdaq
  • Market Cap
  • GCTK 7.6M
  • BREA 9.1M
  • IPO Year
  • GCTK N/A
  • BREA 2023
  • Fundamental
  • Price
  • GCTK $0.24
  • BREA $0.64
  • Analyst Decision
  • GCTK
  • BREA
  • Analyst Count
  • GCTK 0
  • BREA 0
  • Target Price
  • GCTK N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • GCTK 557.4K
  • BREA 497.9K
  • Earning Date
  • GCTK 11-14-2024
  • BREA 12-27-2024
  • Dividend Yield
  • GCTK N/A
  • BREA N/A
  • EPS Growth
  • GCTK N/A
  • BREA N/A
  • EPS
  • GCTK N/A
  • BREA N/A
  • Revenue
  • GCTK N/A
  • BREA $1,268,367.00
  • Revenue This Year
  • GCTK N/A
  • BREA N/A
  • Revenue Next Year
  • GCTK N/A
  • BREA N/A
  • P/E Ratio
  • GCTK N/A
  • BREA N/A
  • Revenue Growth
  • GCTK N/A
  • BREA 606.55
  • 52 Week Low
  • GCTK $0.20
  • BREA $0.50
  • 52 Week High
  • GCTK $4.95
  • BREA $3.00
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 23.92
  • BREA 43.47
  • Support Level
  • GCTK $0.20
  • BREA $0.65
  • Resistance Level
  • GCTK $0.32
  • BREA $0.73
  • Average True Range (ATR)
  • GCTK 0.03
  • BREA 0.10
  • MACD
  • GCTK 0.06
  • BREA 0.00
  • Stochastic Oscillator
  • GCTK 24.45
  • BREA 13.85

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: